Kinetics of BCR-ABL Transcripts in Imatinib Mesylate treated Chronic Phase CML (CPCML), A Predictor of Response and Progression Free Survival. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.